1,3-Diphenethylurea
CAS No. 5467-84-5
1,3-Diphenethylurea( N,N'-bis(2-phenylethyl)urea | 1,3-bis(2-phenylethyl)urea | ZINC150349 )
Catalog No. M29515 CAS No. 5467-84-5
1,3-Diphenethylurea is a marine derived natural products found in Lissoclinum patella.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 80 | In Stock |
|
| 25MG | 186 | In Stock |
|
| 50MG | 296 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name1,3-Diphenethylurea
-
NoteResearch use only, not for human use.
-
Brief Description1,3-Diphenethylurea is a marine derived natural products found in Lissoclinum patella.
-
Description1,3-Diphenethylurea is a marine derived natural products found in Lissoclinum patella.
-
In Vitro——
-
In Vivo——
-
SynonymsN,N'-bis(2-phenylethyl)urea | 1,3-bis(2-phenylethyl)urea | ZINC150349
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5467-84-5
-
Formula Weight268.35
-
Molecular FormulaC17H20N2O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NCCc1ccccc1)NCCc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Boc-NH-PEG11-OH
Boc-NH-PEG11-OH is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Chloramine-T
Tosylchloramide or N-chloro tosylamide, sodium salt, sold as chloramine-T, is a N-chlorinated and N-deprotonated sulfonamide used as a biocide and a mild disinfectant.
-
Amylin (8-37) (human...
Amylin (8-37), human is a fragment of human Amylin. Amylin (8-37), human has direct vasodilator effects in the isolated mesenteric resistance artery of the rat. Human Amylin is a small hormone secreted by pancreatic β-cells that forms aggregates under insulin deficiency metabolic conditions, and it constitutes a pathological hallmark of type II diabetes mellitus.
Cart
sales@molnova.com